PTCH1 and nevoid basal cell carcinoma syndrome: In the case of the HH pathway, the target was uncovered as a result of the gene mapping studies, demonstrating that basal cell nevus carcinoma syndrome (BCNS), also known as Gorlin syndrome, is a consequence of mutations in Patched-1 (PTCH1), the receptor for HH ligands [2,3].